Page last updated: 2024-12-10

nc 5z

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

NC 5Z: photoaffinity ligand for octopamine receptors [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3035914
CHEMBL ID300893
MeSH IDM0167741

Synonyms (9)

Synonym
nc 5z
CHEMBL300893
n-(4-azido-2,6-diethylphenyl)-4,5-dihydro-1h-imidazol-2-amine
2-((4-azido-2,6-diethylphenyl)imino)imidazolidine
121158-53-0
1h-imidazol-2-amine, n-(4-azido-2,6-diethylphenyl)-4,5-dihydro-
2-(2,6-diethyl-4-azidophenylimino)imidazolidine
nc-5z
DTXSID50153171
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID145915V max is determined from stimulation of firefly light organ adenylate cyclase1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
A probe for octopamine receptors: synthesis of 2-[(4-azido-2,6-diethylphenyl)imino]imidazolidine and its tritiated derivative, a potent reversible-irreversible activator of octopamine-sensitive adenylate cyclase.
AID27135Kinetic constant (Ka) of compound against octopamine receptor1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
A probe for octopamine receptors: synthesis of 2-[(4-azido-2,6-diethylphenyl)imino]imidazolidine and its tritiated derivative, a potent reversible-irreversible activator of octopamine-sensitive adenylate cyclase.
AID232136Ratio of (Ka) of octopamine to that of compound1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
A probe for octopamine receptors: synthesis of 2-[(4-azido-2,6-diethylphenyl)imino]imidazolidine and its tritiated derivative, a potent reversible-irreversible activator of octopamine-sensitive adenylate cyclase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (60.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.60

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.60 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.39 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.60)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]